Abstract:Anti-Müllerian hormone (AMH) is a dimeric glycoprotein and a member of the transforming growth factor-beta (TGF-β) family. It has been more than 17 years since the measurement of serum AMH as a biomarker first allowed the quantitative assessment of ovarian reserve. Meanwhile, the implication of AMH has been expanding. AMH regulates follicular development in the ovary and also plays an important neuroendocrine role outside the gonads. There are certain associations between AMH and reproductive outcomes such as miscarriage, live birth, preterm birth and hypertensive disorders in pregnancy. This article reviews the latest research progress of AMH in association with reproductive outcomes, with a view to provide a reference for the clinical work of obstetrics and gynecology.

Research progress of anti-Müllerian hormone in female reproductive outcomes